Genetics: The bridge to
more personalized healthcare.
We’re more equipped than ever to realize the promise of healthcare that is tailored specifically to you. We surveyed both doctors and patients in the U.S. who agree that the time is right to make this concept a reality.† A key missing ingredient? Your genetics.
A healthier U.S. is within reach, but we’re not quite there. Yet.
of people in the U.S. don't feel healthy today
of people in the U.S. don’t feel in control of their health
And while patients trust their doctors, there's a gap in the care they want and the care they’re getting.
of patients want advice tailored to them
of patients say that's what they are getting
However, there is a way to help bridge this gap and provide more personalized, trusted care:
Doctors see the opportunity.
of doctors say genetics is an important part of a patient’s complete health picture
of doctors say that genetic testing could help them provide more personalized care
of doctors feel using genetic testing could lead to better outcomes for their patients
Many doctors encounter a clinical case where genetics plays a role at least weekly and believe that more personalized care could help improve patient adherence.
And patients agree.
of patients say they’d be more likely to follow a doctor’s advice if they knew their genetic profile was used to personalize their care
23andMe Health customers are already taking action based on genetic data.
of 23andMe Health customers surveyed took healthy actions after reviewing their genetic health reports†
Gina is taking action:
“My oncologist turned and looked at me when he was leaving the room and said ‘23andMe, huh? That test saved your life.’”GINA BURRIS, 23andMe customer who learned she had a greatly increased risk for breast and ovarian cancer
And so is Peter, a primary care physician:
“The data provided by the 23andMe test is actionable and can help the primary care physician make better decisions.”PETER SCHWARTZ, MD, a primary care physician and 23andMe customer
23andMe is leading the way.
“I am excited about a future where genetic information becomes the foundation of personalized health. Since starting the company, 23andMe has been focused on helping our customers – and the world – benefit from genetics-based prevention and treatment.”ANNE WOJCICKI, 23andMe Co-founder and CEO
Discover how your DNA can influence your health with 23andMe.
Personalized genetic insights from our Health plus Ancestry kit can give you a more complete picture of your health.Learn more about our Health + Ancestry Service
† Based on 2022 surveys, designed by 23andMe, Medscape, and Material Holdings LLC, of approximately 1,000 doctors and approximately 1,500 patients ; Based on 2019 survey, designed by 23andMe and M/A/R/C Research, of approximately 1,000 23andMe Health + Ancestry customers.
Stay in the know.
Keep up-to-date with new discoveries, new features, and exclusive promotions on our DNA testing kits and services.
*The 23andMe PGS test uses qualitative genotyping to detect select clinically relevant variants in the genomic DNA of adults from saliva for the purpose of reporting and interpreting genetic health risks. It is not intended to diagnose any disease. Your ethnicity may affect the relevance of each report and how your genetic health risk results are interpreted. Each genetic health risk report describes if a person has variants associated with a higher risk of developing a disease, but does not describe a person’s overall risk of developing the disease. The test is not intended to tell you anything about your current state of health, or to be used to make medical decisions, including whether or not you should take a medication, how much of a medication you should take, or determine any treatment. Warnings & Limitations: The 23andMe PGS Genetic Health Risk Report for BRCA1/BRCA2 (Selected Variants) is indicated for reporting of the 185delAG and 5382insC variants in the BRCA1 gene and the 6174delT variant in the BRCA2 gene. The report describes if a woman is at increased risk of developing breast and ovarian cancer, and if a man is at increased risk of developing breast cancer or may be at increased risk of developing prostate cancer. The three variants included in this report are most common in people of Ashkenazi Jewish descent and do not represent the majority of BRCA1/BRCA2 variants in the general population. This report does not include variants in other genes linked to hereditary cancers and the absence of variants included in this report does not rule out the presence of other genetic variants that may impact cancer risk. The PGS test is not a substitute for visits to a healthcare professional for recommended screenings or appropriate follow-up. Results should be confirmed in a clinical setting before taking any medical action. For important information and limitation regarding each genetic health risk report, visit 23andme.com/test-info/